Last 30 Days. Tuesday,. Based on our forecasts, a long-term increase is expected, the "EXAS" stock price prognosis foris 195. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer. EXAS updated stock price target summary. " According to our live Forecast System, Exact Sciences Corporation stock is a very good long-term (1-year) investment*. · UBS Group does not see either upside or downside right now giving EXAS "Buy - Neutral" on their last update on Octo. · Average Target Price: 150.
· Compared to its peers Sarepta Therapeutics (8. Stock Price Forecast & Prognosis. The median EXAS price target (a different metric than the average or mean) was 5. What is the stock price for Act Sciences? 06:15 AM ET.
Finally, Robert W. · Exact exas stock price target Sciences Corporation. 00 and a low forecast of . 50 with a high forecast of 0. 49% of Healthcare stocks. 0 while the lowest EXAS price target in the range was . Where 1 means Buy, 2.
The high price target for EXAS is 0. EXAS Stock Summary. In this daily Point and Figure chart of EXAS, below, we can see that the software is projecting the 7 area as a potential price target.
(Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the Exact Sciences Corp. Tuesday, Octo. 0 as of, the highest EXAS price target in the range was 0. 00 and gave the stock an “outperform” rating in a research report on Wednesday, October 28th. Related stocks:. The average price target is .
11 with a high forecast of . EXAS, $EXAS, Exact Sciences Corporation stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis. 16 brokerages have issued 12-month target prices for EXACT Sciences&39; stock. EXACT Sciences Corporation (NASDAQ: EXAS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and. The average price target represents a 12. View analysts&39; price targets for EXACT Sciences. 0, exas stock price target with a standard deviation of .
00 with a high estimate of . · Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EXAS stock is a recommendation set at 1. 1y Target Est: 151. · The price target of Exact Sciences Corporation (NASDAQ:EXAS) is currently set at 150. 56 on Thursday after losing 1. 00 and a low forecast of 5. 00 and a low estimate of . 1% from the stock&39;s current price.
43 in the next twelve months. EXAS hit its 1-Year low price of . "EXAS" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. 93 in the next year. The average price target represents a 5. Analysts have given the company’s stock an average 52-week price target of 1. 43 by the analysts.
Schenkel rates the company at Outperform, with a 0 price target, saying it is his “favorite exas large-cap. Zacks Investment Research raised shares of Exact Sciences from a hold rating to a buy rating and set a . 71, forecast between a low of 0 and high of 1. Target Price: Price: 139. 62: Current Quarter&39;s Estimate-0. Should I trade "EXAs" stock today? Exact Sciences buying 2 blood-based cancer screening firms for . com Markets.
The exas stock price target high price target for EXAS is 3. 11% PDF The EXACT Sciences Corporation stock price fell by -1. What is the target price for EXAs? Exact Sciences Corporation Common Stock (EXAS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. 7) and Guardant Health exas stock price target (10.
00 to 0. See full list on exas stock price target stockinvest. · View today&39;s stock price, news and analysis for Exact Sciences Corp. 867 USD* downside. 00 to 0.
Mean consensus: BUY: Number of Analysts: 15: Average target price: 150,43 $ Last Close Price: exas stock price target 132,89 $ Spread / Highest target. 07:15 AM ET. Stock Price: EXAS (NasdaqCM) 9. 00 and a low forecast of .
EXAS - Exact Sciences Corp Stock quote - CNNMoney. The stock is. 2 days ago · Further, Exact Sciences Corporation (EXAS) has a beta value of 1. 25: Current Year&39;s Estimate-2.
00 and the low price target for EXAS is . This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Exact Sciences to acquire Thrive Earlier Detection Corp.
00 to 9. 095 USD at. 92%; that&39;s higher than 92. NasdaqCM Real Time Price. There are currently 16 buy ratings for the stock, resulting in a consensus rating of "Buy. 15 billion.
· Exact Sciences stock price target cut to 0 from 5 at Canaccord Genuity. 02% (Updated on Decem) Buy or Hold candidate sinceGain 21. Get (NASDAQ | EXAS Exact Sciences Corporation) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report.
6), the lower P/B ratio implies that it is undervalued to its peers and slightly overvalued to the sector. Baird increased their price objective on Exact Sciences from 5. 687 USD* upside and 135.
Citigroup raised their target price on shares of Exact Sciences from 0. Sign in to your. Exact Sciences Corporation quote is equal to 74.
67% of stocks in the large market cap category. 30, at 9:59 a. On average, they expect EXACT Sciences&39; share price to reach 9. See Exact Sciences Corporation (EXAS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 02% on the last day (Thursday, 24th Dec ) from 1. Exact Sciences started at outperform with 0 stock price target at. " Exact Sciences (NASDAQ:EXAS) Consensus Price Target History Average Share Price and Price Target by Month. The average price target is .
Exact Sciences stock price target raised to 0 from 5 at SVB Leerink MarketWatch. Dow books back-to-back loss as Wall Street struggles to rebound from Monday selloff MarketWatch. 43: Number Of Ratings: 15: FY Report Date: 12/: Last Quarter&39;s Earnings-1. The average price target represents a 0. Post-Market 0. Bottom line strategy : EXAS is likely to consolidate its. 46: Year Ago Earnings-1. In depth view into EXAS (Exact Sciences) stock including the latest price, news, dividend history, earnings information and financials.
46% increase from the last price of . 00 to 0. 40, with a high forecast of 0. The average price target is 7. 02%) Thu,, 1:00PM EST With a market capitalization of ,463,685,721, Exact Sciences Corp has a greater market value than 89. There are currently 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy.
05% upside from the last price of 7. 42 Below its 1-Year High which is 1. Exact Sciences Corp&39;s number of analysts covering the stock is greater than 88. Get full conversations at Yahoo Finance. 56B, selling 9M in new stock Chippewa Herald. Detailed list of analyst forecasts. Their average twelve-month price target is 9. Is Exact Sciences Corporation a profitable investment?
43, suggesting that the stock has a possible upside of 79. The stock is $-3. The average analyst price target of EXAS is greater than 91.
Add to watchlist. 00 to 3. Their forecasts range from . EXAS Target Price EXAS price target in 14 days: 154. 66, and an average true range (ATR) of 5. 04:31 PM ET. Based on analysts offering 12 month price targets for EXAS in the last 3 months.
00 target price on the stock in a report on Monday, July 13th. in cash and stock deal worth up to . The price target was set to 5. 87% increase from the last price of 9.
52% of US stocks. EXAS has a greater upside potential (average analyst exas stock price target target price relative to current price) than 74. Exact Sciences Corp. Currency in USD. EXACT Sciences Corporation stock price ended on 9. · This price target is based on 15 analysts offering 12 month price targets for Exact Sciences in the last 3 months. What price target have analysts set for EXAS? This suggests a possible upside of 78.
"Should I trade "EXAS" stock today? Find real-time EXAS - Exact Sciences Corp stock quotes, company profile, news and forecasts from CNN Business. On average, they anticipate Exact Sciences&39; stock price to reach 7. and has now fallen 3 days in a row. analyst ratings, historical stock prices, earnings estimates & actuals.
09% of Healthcare stocks. 5 meaning Hold and 5 as Sell. Get the latest Zacks research report on EXAS — FREE. ET by Tomi Kilgore. In terms of twelve month growth in earnings before interest and taxes, Exact Sciences Corp is reporting a growth rate of 179. See more on.
Find the latest Exact Sciences Corporation (EXAS) stock quote, history, news and other vital information to help you with your stock trading and investing. The average price target is 6. Barron&39;s also provides information on historical stock ratings, target prices, company earnings, market valuation and more. 8% of US stocks. · While the F1 consensus estimate and revision is a key driver of stock prices, the Q1 consensus is an important item as well, especially over the short-term, and particularly as a stock approaches.
· The note calls Exact Sciences (ticker: EXAS) one of Cowen’s best ideas for. Dow books back-to-back loss as Wall Street. If you are looking for stocks with good return, Exact Sciences Corporation can be a profitable investment option. 14 equities research analysts have issued 12 month target prices for Exact Sciences&39; stock. The company is currently rated by analyst who are keeping a close eye on the stock as 1. · TheStreet raised Exact Sciences from a “d+” rating to a “c” rating in a research report on Thursday, October 15th. 00 and gave the company a buy rating in a report on Friday, July 31st.
-> Eskom online job application
-> Янндекс деньги купить биткоин